title: [Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response].
authors.forename: C
authors.initials: C
authors.lastname: Confavreux
authors.forename: S
authors.initials: S
authors.lastname: Vukusic
authors.forename: T
authors.initials: T
authors.lastname: Arbizu
authors.forename: B
authors.initials: B
authors.lastname: Brochet
authors.forename: M
authors.initials: M
authors.lastname: Clanet
authors.forename: G
authors.initials: G
authors.lastname: Edan
authors.forename: L
authors.initials: L
authors.lastname: Kappos
authors.forename: S
authors.initials: S
authors.lastname: Suissa
mesh_terms: D003711:Demyelinating Diseases / Q000209:etiology* / Q000473:pathology; D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000009:adverse effects*; D006801:Humans; D012598:Sclerosis; D014614:Vaccines, Synthetic / Q000009:adverse effects
chemical_list: D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic